These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30590759)

  • 1. Randomization procedures for multicomponent behavioral intervention factorial trials in the multiphase optimization strategy framework: challenges and recommendations.
    Gallis JA; Bennett GG; Steinberg DM; Askew S; Turner EL
    Transl Behav Med; 2019 Nov; 9(6):1047-1056. PubMed ID: 30590759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simulation and minimization: technical advances for factorial experiments designed to optimize clinical interventions.
    Kuhn J; Sheldrick RC; Broder-Fingert S; Chu A; Fortuna L; Jordan M; Rubin D; Feinberg E
    BMC Med Res Methodol; 2019 Dec; 19(1):239. PubMed ID: 31842765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using the Multiphase Optimization Strategy (MOST) framework to test intervention delivery strategies: a study protocol.
    Broder-Fingert S; Kuhn J; Sheldrick RC; Chu A; Fortuna L; Jordan M; Rubin D; Feinberg E
    Trials; 2019 Dec; 20(1):728. PubMed ID: 31842963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of implementation strategies using the Multiphase Optimization STratgey (MOST) framework: Practical guidance using the factorial design.
    Szeszulski J; Guastaferro K
    Transl Behav Med; 2024 Jun; ():. PubMed ID: 38906703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The preparation phase in the multiphase optimization strategy (MOST): a systematic review and introduction of a reporting checklist.
    Landoll RR; Vargas SE; Samardzic KB; Clark MF; Guastaferro K
    Transl Behav Med; 2022 Feb; 12(2):291-303. PubMed ID: 34850214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews.
    Clyburne-Sherin AV; Thurairajah P; Kapadia MZ; Sampson M; Chan WW; Offringa M
    Trials; 2015 Sep; 16():417. PubMed ID: 26385379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of dynamic block randomization and minimization in randomized trials: a simulation study.
    Xiao L; Lavori PW; Wilson SR; Ma J
    Clin Trials; 2011 Feb; 8(1):59-69. PubMed ID: 21335590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reporting of Factorial Randomized Trials: Extension of the CONSORT 2010 Statement.
    Kahan BC; Hall SS; Beller EM; Birchenall M; Chan AW; Elbourne D; Little P; Fletcher J; Golub RM; Goulao B; Hopewell S; Islam N; Zwarenstein M; Juszczak E; Montgomery AA
    JAMA; 2023 Dec; 330(21):2106-2114. PubMed ID: 38051324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use and reporting of restricted randomization: a review.
    Higham R; Tharmanathan P; Birks Y
    J Eval Clin Pract; 2015 Dec; 21(6):1205-11. PubMed ID: 26200039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus Statement for Protocols of Factorial Randomized Trials: Extension of the SPIRIT 2013 Statement.
    Kahan BC; Hall SS; Beller EM; Birchenall M; Elbourne D; Juszczak E; Little P; Fletcher J; Golub RM; Goulao B; Hopewell S; Islam N; Zwarenstein M; Chan AW; Montgomery AA
    JAMA Netw Open; 2023 Dec; 6(12):e2346121. PubMed ID: 38051535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restricted randomization of ZAMSTAR: a 2 x 2 factorial cluster randomized trial.
    Sismanidis C; Moulton LH; Ayles H; Fielding K; Schaap A; Beyers N; Bond G; Godfrey-Faussett P; Hayes R
    Clin Trials; 2008; 5(4):316-27. PubMed ID: 18697846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Positive Emotions after Acute Coronary Events behavioral health intervention: Design, rationale, and preliminary feasibility of a factorial design study.
    Huffman JC; Albanese AM; Campbell KA; Celano CM; Millstein RA; Mastromauro CA; Healy BC; Chung WJ; Januzzi JL; Collins LM; Park ER
    Clin Trials; 2017 Apr; 14(2):128-139. PubMed ID: 28079394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A scoping review described diversity in methods of randomization and reporting of baseline balance in stepped-wedge cluster randomized trials.
    Nevins P; Davis-Plourde K; Pereira Macedo JA; Ouyang Y; Ryan M; Tong G; Wang X; Meng C; Ortiz-Reyes L; Li F; Caille A; Taljaard M
    J Clin Epidemiol; 2023 May; 157():134-145. PubMed ID: 36931478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using decision analysis for intervention value efficiency to select optimized interventions in the multiphase optimization strategy.
    Strayhorn JC; Cleland CM; Vanness DJ; Wilton L; Gwadz M; Collins LM
    Health Psychol; 2024 Feb; 43(2):89-100. PubMed ID: 37535575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomization in clinical trials: conclusions and recommendations.
    Lachin JM; Matts JP; Wei LJ
    Control Clin Trials; 1988 Dec; 9(4):365-74. PubMed ID: 3203526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distributive randomization: a pragmatic fractional factorial design to screen or evaluate multiple simultaneous interventions in a clinical trial.
    Haviari S; Mentré F
    BMC Med Res Methodol; 2024 Mar; 24(1):64. PubMed ID: 38468221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT).
    Butcher NJ; Monsour A; Mew EJ; Szatmari P; Pierro A; Kelly LE; Farid-Kapadia M; Chee-A-Tow A; Saeed L; Monga S; Ungar W; Terwee CB; Vohra S; Fergusson D; Askie LM; Williamson PR; Chan AW; Moher D; Offringa M
    Trials; 2019 Mar; 20(1):161. PubMed ID: 30841935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.